STOCK TITAN

Agronomics Limited leads US$5m Investment in SuperMeat

(Moderate)
(Positive)
Tags

Agronomics (OTC:AGNMF) is leading a targeted US$10 million Series A-4 financing for portfolio company SuperMeat, with an initial US$6 million raised from Agronomics and affiliates.

Agronomics will invest US$5 million via 26,805,903 new shares at 13.78p, increasing its fully diluted SuperMeat stake to about 27.8%. Total Agronomics investment in SuperMeat will reach approximately £15.2 million. Post-admission, Agronomics’ share count will be 1,083,381,111.

Loading...
Loading translation...

Positive

  • US$5 million SuperMeat investment via equity at 13.78p per share
  • Issue price represents approximately 109% premium to 6.60p market price
  • Agronomics’ fully diluted SuperMeat holding increases to about 27.8%
  • Total historical investment in SuperMeat reaches approximately £15.2 million
  • SuperMeat raises US$6 million initial close toward US$10 million target round
  • New shares subject to 12‑month lock-in and orderly market conditions

Negative

  • 26,805,903 new Agronomics shares issued, increasing total share capital to 1,083,381,111

News Market Reaction – AGNMF

+4.65%
+4.65% Session close to close

In the May 12 session, AGNMF gained 4.65%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Agronomics Limited
("Agronomics" or the "Company")

Agronomics leads US$ 5 million investment in SuperMeat as part of targeted US$ 10 million Series A-4 financing
Issue of Equity and TVR

DOUGLAS, ISLE OF MAN / ACCESS Newswire / May 12, 2026 / Agronomics Limited (AIM:ANIC), the leading listed company focused on clean food, is pleased to announce that its portfolio company SuperMeat The Essence of Meat Ltd. ("SuperMeat") has completed an initial closing of its Series A-4 financing round, raising US$ 6 million from Agronomics and New Agrarian Company Limited ("New Agrarian"), an affiliated company. Milk & Honey Ventures and other existing investors have also subscribed as part of a targeted US$ 10 million financing.

Agronomics is investing US$ 5 million in the round through the issue of new ordinary shares in the Company to SuperMeat, with New Agrarian participating with a US$ 1 million cash investment.

The US$ 5 million consideration due from Agronomics will be satisfied in full by the issue of 26,805,903 new ordinary shares of the Company, each new share issued at a price equal to 13.78 pence (being the net asset value per share as at 31 December 2025 and a premium of approximately 109% to the closing mid-market price of 6.60 pence on 8 May 2026). The new shares shall be subject to agreed lock-in and orderly market arrangements for a year from Admission. In particular, SuperMeat shall be restricted in relation to its shareholding from a) releasing more than 1/12th of the Agronomics shares per calendar month, b) trading more than 10% of the prior day's volume, c) trading below 95% opening price, and d) appointing a third-party broker without first giving a right of first refusal to the Company's appointed broker(s) to sell their shares. The lock-in restrictions will not apply in certain circumstances such as an offer for the Company.

SuperMeat is focused on the production of cultivated meat. The funding is expected to support SuperMeat's commercialization strategy through a licensing-led model, with Switzerland identified as the initial target launch market. SuperMeat has entered into an R&D and technology development framework agreement with Ajinomoto and has extended its collaboration agreement with Micarna, a subsidiary of Migros Group. Near-term milestones include joint product development with Ajinomoto, a consumer validation study led by Migros in Switzerland, process verification at commercial scale and a Swiss regulatory submission. SuperMeat is also progressing a reorganization under a UK holding company as it continues its international expansion.

This follows SuperMeat's November 2025 fundraise of US$ 3.5 million through the issue of a Simple Agreement for Future Equity (a "SAFE"), in which Agronomics invested US$ 2 million, comprising US$ 0.75 million in cash and US$ 1.25 million in new Agronomics shares, with Milk & Honey Ventures also participating.

SuperMeat has also reported a number of operational milestones in recent periods. In March 2024, it published a life-cycle analysis conducted by CE Delft which estimated that its cultivated chicken could generate approximately 50% lower carbon emissions than conventionally farmed chicken. In November 2024, SuperMeat announced a cost-efficiency milestone indicating the potential to produce 100% cultivated chicken (85% muscle, 15% fat) at an estimated cost of approximately US$ 11.79 per pound at scale, broadly in line with premium pasture-raised chicken in the US.

Jim Mellon, Executive Chair of Agronomics, said: "SuperMeat's Series A-4 financing marks an important step in its development and reflects continued progress towards commercial launch. Having supported the business since 2020, we believe the company is well positioned to advance its licensing-led strategy and we are pleased to continue backing the team through this next phase of growth."

Agronomics first invested in SuperMeat in December 2020 and, following this investment, will have invested a total of £15.2 million. As part of the Series A-4 round, the November 2025 SAFE investment has converted into equity, with the shares now forming part of Agronomics' holding in SuperMeat. Following the completion of this round, Agronomics will hold approximately 27.8% of SuperMeat on a fully diluted basis. The Series A 4 fundraise is not expected to have a material impact on the Company's carrying value of its investment in SuperMeat.

TVR

Application has been made for the new shares to be admitted to trading on AIM, with admission expected on 15 May 2026. Post-admission, the Company's issued share capital will total 1,083,381,111 Ordinary Shares, all with voting rights. The Company does not hold any Ordinary Shares in Treasury. Shareholders should therefore use 1,083,381,111 as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE MARKET ABUSE REGULATION (EU No. 596/2014) AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

About SuperMeat

SuperMeat stands at the forefront of the cultivated meat sector, championing the move towards sustainable, nutritious, and animal-friendly meat production. The company has established a pivotal continuous process, setting a new standard in the production of cultivated meat. SuperMeat has formed strategic partnerships with leading food companies, underscoring its commitment to working together to create a better food system.

About Agronomics

Agronomics is a leading London-listed company focused on investment opportunities within the field of clean food. The Company has established a portfolio of over 20 companies developing technologies that produce food and materials historically derived from animals, offering solutions for improved sustainability, human health, and food security.

A full list of Agronomics' portfolio companies is available at www.agronomics.im.

For further information, please contact:

Agronomics Limited

Beaumont
Cornish Limited

Cavendish Capital
Markets
Limited

Canaccord Genuity
Limited

33Seconds
Limited

The Company

Nomad

Joint Broker

Joint Broker

Public Relations

Jim Mellon
Denham Eke

Roland Cornish
James Biddle

Giles Balleny
Michael Johnson

Andrew Potts
Harry Pardoe

Jack Ferris
Joel Watson

+44 (0) 1624 639396
info@agronomics.im

+44 (0) 207 628 3396

+44 (0) 207 397 8900

+44 (0) 207 523 8000

agronomics@33seconds.co

Nominated Adviser

Beaumont Cornish Limited ("Beaumont Cornish") is the Company's Nominated Adviser and is authorized and regulated by the FCA. Beaumont Cornish's responsibilities as the Company's Nominated Adviser, including a responsibility to advise and guide the Company on its responsibilities under the AIM Rules for Companies and AIM Rules for Nominated Advisers, are owed solely to the London Stock Exchange. Beaumont Cornish is not acting for and will not be responsible to any other persons for providing protections afforded to customers of Beaumont Cornish nor for advising them in relation to the proposed arrangements described in this announcement or any matter referred to in it.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

SOURCE: Agronomics Limited



View the original press release on ACCESS Newswire

FAQ

What did Agronomics (AGNMF) announce about its SuperMeat investment on 12 May 2026?

Agronomics announced it is leading SuperMeat’s Series A-4 financing, contributing US$5 million of an initial US$6 million close. According to Agronomics, the round targets US$10 million to support SuperMeat’s commercialization and licensing strategy.

How many new Agronomics (AGNMF) shares are issued for the SuperMeat financing and at what price?

Agronomics will issue 26,805,903 new ordinary shares to SuperMeat at 13.78 pence per share. According to Agronomics, this price equals its 31 December 2025 NAV and is about a 109% premium to the 6.60 pence closing price.

What ownership stake in SuperMeat will Agronomics (AGNMF) hold after the Series A-4 round?

After completion of the Series A-4 financing, Agronomics will hold approximately 27.8% of SuperMeat on a fully diluted basis. According to Agronomics, this includes shares from converting the November 2025 SAFE investment into equity.

How does the SuperMeat Series A-4 financing affect Agronomics (AGNMF) share count and voting rights?

The financing adds 26,805,903 new Agronomics shares, taking total issued share capital to 1,083,381,111 shares. According to Agronomics, all these ordinary shares carry voting rights, and none are held in treasury for disclosure calculations.

How much has Agronomics (AGNMF) invested in SuperMeat to date, including the Series A-4 round?

Including the Series A-4 financing, Agronomics will have invested about £15.2 million in SuperMeat. According to Agronomics, this total covers earlier investments such as the November 2025 US$3.5 million SAFE round participation.

What will SuperMeat use the Agronomics (AGNMF) Series A-4 funding for?

SuperMeat plans to use the funding to advance a licensing-led commercialization strategy, initially targeting Switzerland. According to Agronomics, priorities include joint product development, a Swiss consumer validation study, commercial-scale process verification, and a Swiss regulatory submission.